BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28156048)

  • 21. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma.
    Taga M; Hoshino H; Low S; Imamura Y; Ito H; Yokoyama O; Kobayashi M
    Urol Oncol; 2015 Nov; 33(11):496.e1-9. PubMed ID: 26137907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.
    Fernandes E; Sores J; Cotton S; Peixoto A; Ferreira D; Freitas R; Reis CA; Santos LL; Ferreira JA
    Theranostics; 2020; 10(11):4903-4928. PubMed ID: 32308758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of sialylated glycoproteins in Doxorubicin-treated hepatoma cells with glycoproteomic analyses.
    Azuma K; Serada S; Takamatsu S; Terao N; Takeishi S; Kamada Y; Naka T; Miyoshi E
    J Proteome Res; 2014 Nov; 13(11):4869-77. PubMed ID: 25158113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
    Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
    J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral response against sialyl-Le(a) glycosylated protein species in esophageal cancer: Insights for immunoproteomic studies.
    Fernandes E; Peixoto A; Neves M; Afonso LP; Santos LL; Ferreira JA
    Electrophoresis; 2015 Dec; 36(23):2902-7. PubMed ID: 26333169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
    Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
    J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
    Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
    HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sialylation: an Avenue to Target Cancer Cells.
    Vajaria BN; Patel KR; Begum R; Patel PS
    Pathol Oncol Res; 2016 Jul; 22(3):443-7. PubMed ID: 26685886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case for protein-level and site-level specificity in glycoproteomic studies of disease.
    Schumacher KN; Dodds ED
    Glycoconj J; 2016 Jun; 33(3):377-85. PubMed ID: 27007620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up.
    Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M
    J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers.
    Hoja-Łukowicz D; Szwed S; Laidler P; Lityńska A
    Biochimie; 2018 Aug; 151():14-26. PubMed ID: 29802864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of tumor cell sialylation in pancreatic cancer progression.
    Marciel MP; Haldar B; Hwang J; Bhalerao N; Bellis SL
    Adv Cancer Res; 2023; 157():123-155. PubMed ID: 36725107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Sialyl-Tn in Cancer.
    Munkley J
    Int J Mol Sci; 2016 Feb; 17(3):275. PubMed ID: 26927062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terminal glycotope expression on milk fibronectin differs from plasma fibronectin and changes over lactation.
    Orczyk-Pawiłowicz M; Hirnle L; Berghausen-Mazur M; Kątnik-Prastowska I
    Clin Biochem; 2015 Feb; 48(3):167-73. PubMed ID: 25464017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
    Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
    J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer.
    Mhawech-Fauceglia P; Ali L; Cheney RT; Groth J; Herrmann FR
    J Clin Pathol; 2009 Aug; 62(8):710-4. PubMed ID: 19638542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple mucin-type cancer associated antigens are pre-cancerous biomarkers during 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
    Berriel E; Hill M; Barcia JJ; Ubillos L; Gonzalez M; Detjen G; Rondan M; Navarrete H; Osinaga E
    Oncol Rep; 2005 Jul; 14(1):219-27. PubMed ID: 15944793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-derived sialyl-Tn-positive invasive bladder cancer xenografts in nude mice: an exploratory model study.
    Bernardo C; Costa C; Amaro T; Gonçalves M; Lopes P; Freitas R; Gärtner F; Amado F; Ferreira JA; Santos L
    Anticancer Res; 2014 Feb; 34(2):735-44. PubMed ID: 24511007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.